-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
-
Summary
-
Outlook Therapeutics, Inc. quarterly/annual Depreciation history and growth rate from 2020 to 2022.
- Outlook Therapeutics, Inc. Depreciation for the quarter ending September 30, 2022 was $40.9K, unchanged year-over-year.
- Outlook Therapeutics, Inc. Depreciation for the twelve months ending September 30, 2022 was $164K, a 0% increase year-over-year.
- Outlook Therapeutics, Inc. annual Depreciation for 2022 was $164K, a 0% increase from 2021.
- Outlook Therapeutics, Inc. annual Depreciation for 2021 was $164K, a 25.4% decline from 2020.
Depreciation, Trailing 12 Months (USD)
Depreciation, Annual (USD)
Depreciation, YoY Annual Growth (%)